(Q40843448)

24 September 2017

1 reference

title

What is nitric oxide and why are so many people studying it? (English)

1 reference

24 September 2017

Gibaldi M

1

1 reference

24 September 2017

1 June 1993

1 reference

The Journal of Clinical Pharmacology

24 September 2017

1 reference

24 September 2017

33

1 reference

24 September 2017

6

1 reference

24 September 2017

488-496

1 reference

Nitric oxide: a cytotoxic activated macrophage effector molecule

24 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

Nitric oxide: first in a new class of neurotransmitters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

Clinical relevance of endothelium-derived relaxing factor (EDRF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

Endothelial control of vascular tone in large and small coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

Endogenous and exogenous nitrates and their role in myocardial ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

Inhibition of nitric oxide synthesis in septic shock: how much is beneficial?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

Nitric oxide in liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

Inhaled nitric oxide in persistent pulmonary hypertension of the newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

Role of endothelium-derived nitric oxide in the regulation of blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

Nitric oxide-mediated gastric hyperemia decreases ethanol-induced gastric mucosal injury in uremic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

Nitric oxide synthase activity in infantile hypertrophic pyloric stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

Alcohol, Nitric Oxide, and Neurotoxicity: Is There a Connection?—a Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

Possible central role of nitric oxide in conditions clinically similar to cerebral malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

Proposed link between cytokines, nitric oxide and human cerebral malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

21 January 2018

The molecule of the year

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04694.X

10.1002/J.1552-4604.1993.TB04694.X

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

8366174